Direct Actions of Estrogen on Vascular Cells Ameliorates Response to Injury
In spite of significant advances in technique and adjunctive medical treatment, restenosis after percutaneous coronary revascularization remains a major problem. Moreover, women have fared comparatively poorly after percutaneous transluminal coronary angioplasty (PTCA) with less long-term relief of symptoms and a trend towards reduced survival compared to men . Interestingly, two recent retrospective studies have suggested that women who took estrogen replacement therapy (ERT) after their angioplasty had less restenosis  and better long-term outcome  than their nonestrogen taking counterparts.
KeywordsFibrinogen Level Arterioscler Thromb Vasc Biol Plasma Fibrinogen Level Fibrinogen Gene Coronary Heart Disease Development
Unable to display preview. Download preview PDF.
- 2.O’Brien JE, Peterson ED, Keeler GP, et al. Relation between estrogen replacement therapy and restenosis after percutaneous coronary interventions. JACCb 1996;28:1111–18.Google Scholar
- 6.Holm P, Shalmi M, Korsgaard N, Guldhammer B, Skouby SV, Stender S. A partial estrogen receptor agonist with strong antiatherogenic properties without noticeable effect on reproductive tissue in cholesterol-fed female and male rabbits. Arterioscler Thromb Vasc Biol 1997;17:2264–72.PubMedGoogle Scholar
- 11.Rubayni GM, Freay AD, Kauser K, et al. Vascular estrogen receptors and endothelium-derived nitric oxide production in the mouse aorta. J Clin Invest 1997;99:2429–37.Google Scholar
- 15.Bowerman RE, Pinkerton CA, Kirk B, Waller BF. Disruption of a coronary stent during atherectomy for restenosis. Cathet Cardiovasc Design 1993;71:364–66.Google Scholar
- 16.O’Brien ER, Alpers CE, Stewart DK, et al. Proliferation in primary and restenotic coronary atherectomy tissue: Implications for antiproliferative therapy. Circ Res 1993;3:223–31.Google Scholar
- 19.Spyridopoulos I, Losordo DW. Cardiovascular estrogen receptors regulate vascular smooth muscle cell proliferation. In: Forte TM, editor. Hormonal, metabolic, and cellular influences on cardiovascular disease in women. Armonk, NY: Futura Publishing Company, Inc., 1997: 71–97.Google Scholar
- 20.Kim-Schuize S, McGowan KA, Hubchak SC, et al. Expression of an estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996;94:1402–7.Google Scholar
- 41.Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vase Surgery 1994;19:722–26.Google Scholar
- 45.Karas RH, Bieber HE, Baur WE, Mendelsohn ME. Estrogen enhances vascular endothelial growth factor (VEGF) gene expression in human vascular smooth muscle cells. Circulation 1996;94:1–595.(Abstract).Google Scholar